JanOne poised to produce drug for CV, COVID-19 trials
Partnering with Eurofins, the company has verified the developmental batch of its JAN101, aimed to treat cardiovascular conditions and COVID-19.
Archives for September 8, 2020
FSD Pharma announces Phase II trial for potential COVID-19 treatment
The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.
IBM Watson Health, OrbitalRX partner to manage drug shortages
The collaboration combines two solutions to help pharma and healthcare providers deal with myriad challenges associated with limited drug supplies.